| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenue | 21,202,064 | 20,409,400 | 19,510,637 | 18,325,959 |
| Cost of revenue | 4,707,756 | 4,454,408 | 4,667,831 | 4,134,253 |
| Gross profit | 16,494,308 | 15,954,992 | 14,842,806 | 14,191,706 |
| General and administrative | 4,355,636 | 4,279,993 | 4,610,832 | 3,967,799 |
| Sales and marketing | 4,630,560 | 4,009,640 | 4,176,273 | 3,795,320 |
| Research and development | 674,362 | 877,362 | 624,245 | 639,467 |
| Total operating expenses | 9,660,558 | 9,166,995 | 9,411,350 | 8,402,586 |
| Income from operations | 6,833,750 | 6,787,997 | 5,431,456 | 5,789,120 |
| Other income, net | 463,976 | 539,247 | 513,973 | 629,201 |
| Income before provision for income taxes | 7,297,726 | 7,327,244 | 5,945,429 | 6,418,321 |
| Provision for income tax expense | 1,721,074 | 1,553,283 | 1,258,000 | 1,368,830 |
| Net income | 5,576,652 | 5,773,961 | 4,687,429 | 5,049,491 |
| Earnings per share, basic | 0.44 | 0.45 | 0.37 | 0.4 |
| Earnings per share, diluted | 0.43 | 0.45 | 0.37 | 0.4 |
| Weighted average number of shares outstanding, basic | 12,720,812 | 12,715,872 | 12,714,224 | 12,669,741 |
| Weighted average number of shares outstanding, diluted | 12,860,077 | 12,835,408 | 12,825,672 | 12,778,446 |
IRADIMED CORP (IRMD)
IRADIMED CORP (IRMD)